 | Up a level |
Huth, Thorben; Dreher, Emely C; Lemke, Steffen; Fritzsche, Sarah; Sugiyanto, Raisatun N; Castven, Darko; Ibberson, David; Sticht, Carsten; Eiteneuer, Eva; Jauch, Anna; Pusch, Stefan; Albrecht, Thomas; Goeppert, Benjamin; Candia, Julián; Wang, Xin Wei; Ji, Junfang; Marquardt, Jens U; Nahnsen, Sven; Schirmacher, Peter and Roessler, Stephanie (2023). Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer. Science Advances, 9(51), eadh1442. American Association for the Advancement of Science 10.1126/sciadv.adh1442
Heumos, Simon; Dehn, Sandra; Bräutigam, Konstantin; Codrea, Marius C; Schürch, Christian M; Lauer, Ulrich M; Nahnsen, Sven; Schindler, Michael (2022). Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy. Cancer cell international, 22(1), p. 311. BioMed Central 10.1186/s12935-022-02710-y
Spahn, Stephan; Roessler, Daniel; Radu, Pompilia; Gabernet, Gisela; Gladstone, Beryl Primrose; Horger, Marius; Biskup, Saskia; Feldhahn, Magdalena; Nahnsen, Sven; Hilke, Franz J; Scheiner, Bernhard; Dufour, Jean-François; De Toni, Enrico N; Pinter, Matthias; Malek, Nisar P; Bitzer, Michael (2020). Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma. Cancers, 12(12) MDPI AG 10.3390/cancers12123830
